A BILL 
To report data on COVID–19 immigration detention facilities 
and local correctional facilities that contract with U.S. 
Immigration and Customs Enforcement, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘COVID–19 in Immi-
4
gration Detention Data Transparency Act’’. 
5
23:15 Dec 21, 2020
H8913
2 
•HR 8913 IH
SEC. 2. DEFINITIONS. 
1
In this Act: 
2
(1) CBP DETENTION
FACILITY.—The term 
3
‘‘CBP detention facility’’ means any facility used by 
4
U.S. Customs and Border Protection to detain non-
5
citizens. 
6
(2) CDC DIRECTOR.—The term ‘‘CDC Direc-
7
tor’’ means the Director of the Centers for Disease 
8
Control and Prevention. 
9
(3) CONTRACT
DETENTION
FACILITY.—The 
10
term ‘‘contract detention facility’’ means any facility 
11
used for the detention of noncitizens that is operated 
12
by a government agency or a private entity that has 
13
contracted with U.S. Immigration and Customs En-
14
forcement, U.S. Customs and Border Protection, or 
15
the Office of Refugee Resettlement to provide such 
16
detention services, including service processing cen-
17
ters, juvenile detention facilities, family residential 
18
centers, facilities holding noncitizens awaiting re-
19
moval, and similar facilities operating under an 
20
intergovernmental service agreement with any of 
21
such Federal agencies, including intergovernmental 
22
agreements with the United States Marshals Service. 
23
(4) 
COVID–19.—The 
term 
‘‘COVID–19’’ 
24
means the 2019 novel coronavirus disease caused by 
25
the SARS–CoV–2 virus. 
26
23:15 Dec 21, 2020
H8913
3 
•HR 8913 IH
(5) COVID–19 DIAGNOSTIC TEST.—The term 
1
‘‘COVID–19 diagnostic test’’ means a test— 
2
(A) that is an in vitro diagnostic product 
3
(as defined in section 809.3 of title 21, Code of 
4
Federal Regulations) for the detection of 
5
SARS–CoV–2; and 
6
(B) the administration of which— 
7
(i) is approved, cleared, or authorized 
8
under section 510(k), 513, 515, or 564 of 
9
the Federal Food, Drug, and Cosmetic Act 
10
(21 U.S.C. 360(k), 360c, 360e, 360bbb–3); 
11
(ii) the developer has requested, or in-
12
tends to request, emergency use authoriza-
13
tion under section 564 of the Federal 
14
Food, Drug, and Cosmetic Act (21 U.S.C. 
15
360bbb–3), unless and until the emergency 
16
use authorization request under such sec-
17
tion 564 has been denied or the developer 
18
of such test does not submit a request 
19
under such section within a reasonable 
20
timeframe; 
21
(iii) is developed in and authorized by 
22
a State that has notified the Secretary of 
23
Health and Human Services of its inten-
24
23:15 Dec 21, 2020
H8913
4 
•HR 8913 IH
tion to review tests intended to diagnose 
1
COVID–19; or 
2
(iv) is another test that the Secretary 
3
determines appropriate in guidance. 
4
(6) COVID–19 EMERGENCY DATA COLLECTION 
5
PERIOD.—The term ‘‘COVID–19 emergency data 
6
collection period’’ means the period beginning on the 
7
date of enactment of this Act and ending on the 
8
date that is 1 year after the date on which the pub-
9
lic health emergency declaration under section 319 
10
of the Public Health Service Act (42 U.S.C. 247d), 
11
with respect to COVID–19, terminates. 
12
(7) FACILITY STAFF.—The term ‘‘facility staff’’ 
13
includes all individuals who work in a detention fa-
14
cility, including any individual who regularly reports 
15
for work within the detention facility, regardless of 
16
the actual employer of such individual. 
17
(8) ICE 
DETENTION
FACILITY.—The term 
18
‘‘ICE detention facility’’ means any facility used by 
19
U.S. Immigration and Customs Enforcement to de-
20
tain noncitizens, including service processing centers. 
21
(9) ORR 
CONTRACTED
FACILITY
OR
PRO-
22
GRAM.—The term ‘‘ORR contracted facility or pro-
23
gram’’ means any facility or program in which unac-
24
companied noncitizen children are in the care and 
25
23:15 Dec 21, 2020
H8913
5 
•HR 8913 IH
custody of the Department of Health and Human 
1
Services. 
2
(10) PUBLIC HEALTH EMERGENCY.—The term 
3
‘‘public health emergency’’ means— 
4
(A) a national emergency involving Federal 
5
primary responsibility determined to exist by 
6
the President under section 501(b) of the Rob-
7
ert T. Stafford Disaster Relief and Emergency 
8
Assistance Act (42 U.S.C. 5191(b)) with re-
9
spect to a communicable disease; 
10
(B) a national emergency declared by the 
11
President under sections 201 and 301 of the 
12
National Emergencies Act (50 U.S.C. 1621 and 
13
1631) with respect to a communicable disease; 
14
(C) a national public health emergency de-
15
clared by the Secretary of Health and Human 
16
Services under section 319 of the Public Health 
17
Service Act (42 U.S.C. 247d); or 
18
(D) a global pandemic declared by the 
19
World Health Organization. 
20
SEC. 3. COVID–19 DATA COLLECTION REQUIREMENTS. 
21
(a) FEDERAL DETENTION FACILITIES.—The Direc-
22
tor of U.S. Immigration and Customs Enforcement, the 
23
Commissioner of U.S. Customs and Border Protection, the 
24
Director of the Office of Refugee Resettlement, and any 
25
23:15 Dec 21, 2020
H8913
6 
•HR 8913 IH
senior official acting in, or performing the duties of, any 
1
such position shall, during the COVID–19 emergency data 
2
collection period— 
3
(1) post daily updates on the public website of 
4
the applicable agency containing the information de-
5
scribed in section 5 with respect to staff working at 
6
ICE detention facilities, CBP detention facilities, or 
7
ORR contracted facilities or programs, respectively, 
8
and noncitizens detained at such facilities or served 
9
by such programs; 
10
(2) archive, on a weekly basis, the data de-
11
scribed in paragraph (1) so that it remains publicly 
12
accessible and in a machine readable format; and 
13
(3) beginning not later than the earlier of the 
14
date that is 14 days after the date on which the 
15
CDC Director publishes the guidance required under 
16
section 4(a) or 45 days after the date of the enact-
17
ment of this Act, submit weekly reports to the CDC 
18
Director containing the information described in sec-
19
tion 5. 
20
(b) CONTRACT DETENTION FACILITIES.— 
21
(1) IN GENERAL.—Beginning not later than the 
22
earlier of the date that is 14 days after the date on 
23
which the CDC Director publishes the guidance re-
24
quired under section 4(a) or 45 days after the date 
25
23:15 Dec 21, 2020
H8913
7 
•HR 8913 IH
of the enactment of this Act, the head of each con-
1
tract detention facility shall— 
2
(A) submit weekly reports to the Federal 
3
agency with which the facility is under contract 
4
and the public health authority of the State in 
5
which the facility is located containing the data 
6
described in section 5 with respect to staff 
7
working at such facility and noncitizens de-
8
tained at such facility; 
9
(B) post weekly updates containing the 
10
data described in subparagraph (A) on the pub-
11
lic website of the facility, if the facility has a 
12
public website, in a machine readable format, 
13
and archive prior updates so that they remain 
14
publicly accessible; and 
15
(C) submit weekly reports containing the 
16
data referred to in subparagraph (A) to— 
17
(i) the Immigration Detention Om-
18
budsman designated pursuant to section 
19
405 of the Homeland Security Act of 2002 
20
(6 U.S.C. 205); and 
21
(ii) the Office for Civil Rights and 
22
Civil Liberties of the Department of 
23
Homeland Security. 
24
23:15 Dec 21, 2020
H8913
8 
•HR 8913 IH
(2) SUBMISSION
OF
INFORMATION
TO
THE 
1
CDC.—Not later than 24 hours after a Federal agen-
2
cy receives the data described in paragraph (1), the 
3
head of such agency shall— 
4
(A) submit such data to the CDC Director; 
5
and 
6
(B) post such data to the public website of 
7
the agency, which shall be archived weekly and 
8
shall remain publically accessible in a machine 
9
readable format. 
10
(c) USE OF EXISTING APPROPRIATIONS.— 
11
(1) DEPARTMENT
OF
HEALTH
AND
HUMAN 
12
SERVICES.—The Department of Health and Human 
13
Services such use amounts otherwise appropriated 
14
for the Office of Refugee Resettlement to carry out 
15
its responsibilities under this section. 
16
(2) U.S. IMMIGRATION AND CUSTOMS ENFORCE-
17
MENT.—U.S. Immigration and Customs Enforce-
18
ment shall use amounts otherwise appropriated to 
19
the Custody Operations Account to carry out its re-
20
sponsibilities under this section. 
21
(3) U.S. 
CUSTOMS
AND
BORDER
PROTEC-
22
TION.—U.S. Customs and Border Protection shall 
23
use amounts otherwise appropriated to the Procure-
24
23:15 Dec 21, 2020
H8913
9 
•HR 8913 IH
ment, Construction, and Improvements Account to 
1
carry out its responsibilities under this section. 
2
SEC. 4. CDC REPORTS. 
3
(a) GUIDANCE.—Not later than 30 days after the 
4
date of enactment of this Act, the CDC Director shall 
5
issue guidance for immigration detention facilities regard-
6
ing— 
7
(1) the categories of data required to be re-
8
ported under this Act; and 
9
(2) how the CDC Director will determine 
10
whether a Federal or State agency is in compliance 
11
with the requirements under this Act. 
12
(b) PUBLICATION ON WEBSITE.— 
13
(1) IN GENERAL.—Not later than 7 days after 
14
data is reported to the Centers for Disease Control 
15
and Prevention pursuant to section 3, the CDC Di-
16
rector shall make such data available to the public 
17
on the website of the Centers for Disease Control 
18
and Prevention, including all data reported by U.S. 
19
Immigration and Customs Enforcement, U.S. Cus-
20
toms and Border Protection, and the Office of Ref-
21
ugee Resettlement. 
22
(2) WEEKLY ARCHIVAL.—The data referred to 
23
in paragraph (1) shall be archived weekly and shall 
24
23:15 Dec 21, 2020
H8913
10 
•HR 8913 IH
remain publically accessible in a machine readable 
1
format. 
2
(c) REPORTS TO CONGRESS.—Not later than 60 days 
3
after the date of the enactment of this Act, and monthly 
4
thereafter during the COVID–19 emergency data collec-
5
tion period, the CDC Director shall submit a report to 
6
Committee on Health, Education, Labor, and Pensions of 
7
the Senate, the Committee on the Judiciary of the Senate, 
8
the Committee on Homeland Security of the House of 
9
Representatives, and the Committee on the Judiciary of 
10
the House of Representatives that— 
11
(1) summarizes the information submitted by 
12
U.S. Immigration and Customs Enforcement, U.S. 
13
Customs and Border Protection, the Office of Ref-
14
ugee Resettlement, and State public health authori-
15
ties pursuant to section 3; and 
16
(2) analyzes the trends and patterns of the dis-
17
ease outbreak and the care provided in immigration 
18
detention facilities and contracted facilities. 
19
SEC. 5. COVID–19 DATA. 
20
(a) IN GENERAL.—The data described in this section 
21
is the following data with respect to each ICE, CBP, ORR, 
22
and contract detention facility: 
23
(1) TESTING
NUMBERS.—Data related to 
24
COVID–19 diagnostic testing by such facilities, in-
25
23:15 Dec 21, 2020
H8913
11 
•HR 8913 IH
cluding cumulative and new (since the previous 
1
weekly report) counts of— 
2
(A) the number of detained noncitizens 
3
tested for COVID–19, including the dates on 
4
which 
such 
tests 
were 
administered, 
5
disaggregated by— 
6
(i) first-time COVID–19 diagnostic 
7
tests and retests; and 
8
(ii) symptomatic and asymptomatic; 
9
(B) the number of detained noncitizens 
10
who have requested COVID–19 testing, includ-
11
ing the number of such requests that were de-
12
nied and the reasons for such denials; 
13
(C) the number of facility staff tested for 
14
COVID–19, 
disaggregated 
by 
first-time 
15
COVID–19 diagnostic tests and retests; and 
16
(D) the COVID–19 diagnostic test devel-
17
oper and test name for each COVID–19 diag-
18
nostic test conducted. 
19
(2) TEST RESULTS.—Data related to COVID– 
20
19 diagnostic testing outcomes, including cumulative 
21
and new (since the previous weekly report) counts 
22
of— 
23
23:15 Dec 21, 2020
H8913
12 
•HR 8913 IH
(A) the number of confirmed active cases 
1
of COVID–19 among detained noncitizens, 
2
disaggregated by— 
3
(i) first-time COVID–19 diagnostic 
4
tests and retests; and 
5
(ii) the COVID–19 diagnostic test de-
6
veloper and test name for each COVID–19 
7
diagnostic test used to confirm each active 
8
case; 
9
(B) the number of confirmed negative 
10
cases of COVID–19 among detained nonciti-
11
zens, disaggregated— 
12
(i) by first-time COVID–19 diagnostic 
13
tests and retests; and 
14
(ii) the COVID–19 diagnostic test de-
15
veloper and test name for each COVID–19 
16
diagnostic test used to confirm each nega-
17
tive case; 
18
(C) the number of confirmed active cases 
19
of COVID–19 among detention facility staff, 
20
disaggregated by— 
21
(i) first-time COVID–19 diagnostic 
22
tests and retests; and 
23
(ii) the COVID–19 diagnostic test de-
24
veloper and test name for each COVID–19 
25
23:15 Dec 21, 2020
H8913
13 
•HR 8913 IH
diagnostic test used to confirm each active 
1
case; 
2
(D) the number of confirmed negative 
3
cases of COVID–19 among detention facility 
4
staff, disaggregated by— 
5
(i) first-time COVID–19 diagnostic 
6
tests and retests; and 
7
(ii) the COVID–19 diagnostic test de-
8
veloper and test name for each COVID–19 
9
diagnostic test used to confirm each nega-
10
tive case; 
11
(E) the number of COVID–19 diagnostic 
12
tests pending results, disaggregated by detained 
13
noncitizens and detention facility staff; 
14
(F) the average time between testing a de-
15
tained person for COVID–19 and receiving the 
16
results of the COVID–19 diagnostic test; and 
17
(G) the average time between testing a de-
18
tention facility employee for COVID–19 and re-
19
ceiving the results of the COVID–19 diagnostic 
20
test. 
21
(3) CASE
OUTCOMES.—COVID–19 case out-
22
comes, including cumulative and new (since the pre-
23
vious report) counts of— 
24
23:15 Dec 21, 2020
H8913
14 
•HR 8913 IH
(A) the number of detained noncitizens 
1
hospitalized for a case of COVID–19, including 
2
the locations of the hospitals at which the non-
3
citizens are receiving treatment; 
4
(B) the number of detained noncitizens 
5
who have recovered from COVID–19; 
6
(C) the number of detained noncitizens 
7
currently in quarantine and the number of de-
8
tained noncitizens in medical isolation for infec-
9
tion with or exposure to COVID–19; 
10
(D) the number of detained noncitizens 
11
who have completed quarantine and the number 
12
of detained noncitizens who have been released 
13
from medical isolation; 
14
(E) the number of detained noncitizens 
15
identified as having 1 or more COVID–19 risk 
16
factors; 
17
(F) the number of noncitizens who have 
18
been released from detention because of 1 or 
19
more COVID–19 risk factors, disaggregated by 
20
their applicable risk factor; 
21
(G) the number of detained noncitizens 
22
with active COVID–19 cases in the previous 
23
weekly report who are not included in the 
24
present report, disaggregated by the specific 
25
23:15 Dec 21, 2020
H8913
15 
•HR 8913 IH
reason for such exclusion, including release, 
1
negative COVID–19 test, transfer, and absence 
2
of COVID–19 symptoms; 
3
(H) the number of detained noncitizens 
4
who have died from COVID–19; 
5
(I) the number of detained noncitizens who 
6
died after testing positive for COVID–19, but 
7
the official cause of death was not COVID–19; 
8
(J) the number of detention facility staff 
9
hospitalized for a case of COVID–19; 
10
(K) the number of detention facility staff 
11
who have recovered from COVID–19; and 
12
(L) the number of detention facility staff 
13
who have died from a case of COVID–19. 
14
(4) GENERAL MEDICAL ATTENTION.—The num-
15
ber of detained noncitizens who have requested gen-
16
eral medical attention, including the number of such 
17
requests that were denied and the reasons for such 
18
denials. 
19
(5) DAILY POPULATION.—Average daily popu-
20
lation of detained noncitizens for the week preceding 
21
the COVID–19 emergency data collection period and 
22
for all weeks during such period. 
23
(6) TRANSFERRED
NONCITIZENS.—Data re-
24
lated to the COVID–19 testing, results, and case 
25
23:15 Dec 21, 2020
H8913
16 
•HR 8913 IH
outcomes (at the time of release) of noncitizens who 
1
were transferred between detention facilities during 
2
the reporting period, including— 
3
(A) the number of all individuals who were 
4
transferred, including— 
5
(i) the dates on which such transfers 
6
occurred; 
7
(ii) the number of such noncitizens 
8
who were tested and received a result be-
9
fore their transfer; and 
10
(iii) the number of such noncitizens 
11
who were not tested or did not receive a 
12
result before their transfer; 
13
(B) the purposes of such transfers; 
14
(C) the dates on which COVID–19 testing 
15
occurred during the transfer process; 
16
(D) the number of transferees who tested 
17
positive at any point during the transfer proc-
18
ess; and 
19
(E) the number of positive COVID–19 
20
cases in the transferring facility and in the ar-
21
riving facility at the time of each such transfer. 
22
(7) RELEASED NONCITIZENS.—Data related to 
23
the COVID–19 testing, results, and case outcomes 
24
(at the time of release) of noncitizens who were re-
25
23:15 Dec 21, 2020
H8913
17 
•HR 8913 IH
leased from detention, and juvenile noncitizens who 
1
were released from the custody of the Department of 
2
Health and Human Services, during the reporting 
3
period, disaggregated by the type of release, and in-
4
cluding— 
5
(A) individuals released to alternatives to 
6
detention programs as a result of the COVID– 
7
19 public health emergency; and 
8
(B) any recent positive COVID–19 tests 
9
and referrals to external medical care. 
10
(8) REMOVED NONCITIZENS.—Data related to 
11
the COVID–19 testing, results, and case outcomes 
12
(at the time of removal or expulsion) of noncitizens 
13
who were deported from an ICE, CBP, ORR, or 
14
contract detention facility during the reporting pe-
15
riod, including— 
16
(A) any recent positive COVID–19 tests 
17
and referrals to external medical care; 
18
(B) the number of noncitizens removed or 
19
expelled from the United States; 
20
(C) the number of such noncitizens who 
21
were tested and received a result before their 
22
removal or expulsion; and 
23
23:15 Dec 21, 2020
H8913
18 
•HR 8913 IH
(D) the number of such noncitizens who 
1
were not tested or did not receive a result be-
2
fore their removal or expulsion. 
3
(b) DISAGGREGATION OF DATA.— 
4
(1) IN GENERAL.—The data described in sub-
5
section (a) shall be disaggregated by sex, sexual ori-
6
entation, gender identity, age, race, ethnicity, dis-
7
ability, last known place of residence, location at 
8
which the individual is being detained, nationality, 
9
and statutory authority for detention. 
10
(2) EXCLUSION
OF
INDIVIDUALS
INCARCER-
11
ATED FOR NONIMMIGRATION REASONS AT CONTRACT 
12
DETENTION
FACILITIES.—Data regarding individ-
13
uals incarcerated at contract detention facilities for 
14
nonimmigration reasons shall be excluded from the 
15
data described in subsection (a). 
16
(c) DETENTION PERIOD.—The data described in sub-
17
section (a) with respect to detained noncitizens who are 
18
infected with COVID–19 shall include, to the extent prac-
19
ticable, the period of their detention. 
20
SEC. 6. PRIVACY PROTECTIONS. 
21
(a) IN GENERAL.—Any data collected, stored, re-
22
ceived, or published under this Act— 
23
23:15 Dec 21, 2020
H8913
19 
•HR 8913 IH
(1) shall be collected, stored, received, or pub-
1
lished in a manner that protects the privacy of indi-
2
viduals whose information is included in such data; 
3
(2) shall be de-identified or anonymized in a 
4
manner that protects the identity of all individuals 
5
whose information is included in such data; 
6
(3) shall comply with privacy protections pro-
7
vided under the regulations promulgated under sec-
8
tion 264(c) of the Health Insurance Portability and 
9
Accountability Act of 1996 (42 U.S.C. 1320d–2 
10
note); and 
11
(4) shall be limited in use for the purpose of 
12
public health and be protected from all other inter-
13
nal use by any entity that collects, stores, or receives 
14
the data, including use of such data in determina-
15
tions of eligibility (or continued eligibility) in health 
16
plans, and from any other inappropriate uses. 
17
(b) RESTRICTION ON USE OF COVID–19 STATUS IN 
18
IMMIGRATION PROCEEDINGS.—The Government may not 
19
use an noncitizen’s positive COVID–19 test, an nonciti-
20
zen’s treatment for COVID–19 symptoms, or the state of 
21
the COVID–19 pandemic in the noncitizen’s country of 
22
origin as evidence against the noncitizen in any immigra-
23
tion proceeding, including— 
24
23:15 Dec 21, 2020
H8913
20 
•HR 8913 IH
(1) a proceeding to determine if the noncitizen 
1
is a public charge; and 
2
(2) proceedings involving asylum, withholding of 
3
removal, and protection under the Convention 
4
against Torture and Other Cruel, Inhuman or De-
5
grading Treatment or Punishment, done at New 
6
York December 10, 1984. 
7
SEC. 7. COVID–19 SAFETY PROTOCOLS AND PRACTICES. 
8
(a) IN GENERAL.—Not later than 30 days after the 
9
date of the enactment of this Act, the Director of U.S. 
10
Immigration and Customs Enforcement, the Commis-
11
sioner of U.S. Customs and Border Protection, the Direc-
12
tor of the Office of Refugee Resettlement, and any senior 
13
official acting in, or performing the duties of, any such 
14
position shall submit a report to the congressional commit-
15
tees referred to in section 4(c) that identifies, for each 
16
detention facility under the jurisdiction of the applicable 
17
agency head, including contract detention facilities, the 
18
protocols and practices for protecting detainees from expo-
19
sure to the novel coronavirus (SARS–CoV–2), including— 
20
(1) the health standards at the facility, includ-
21
ing— 
22
(A) the standards for transfer to hospital 
23
or other specialized care; 
24
23:15 Dec 21, 2020
H8913
21 
•HR 8913 IH
(B) the procedure for the detained person 
1
to request and obtain a COVID–19 test and as-
2
sociated results; and 
3
(C) detainee access to information about 
4
the facility’s COVID–19 plans and protocols; 
5
(2) the medical care provided to detainees, in-
6
cluding— 
7
(A) the specific efforts to cohort smaller 
8
groups of detained people; 
9
(B) the specific efforts to provide humane 
10
medical isolation to symptomatic people, and 
11
separately, people who have tested positive for 
12
COVID–19; and 
13
(C) the standards for clinical monitoring of 
14
symptomatic and COVID–19 positive detained 
15
persons; and 
16
(3) the sanitation practices at the facility, in-
17
cluding the frequency and amount of detainees’ ac-
18
cess to soap and masks. 
19
(b) NOTIFICATION OF OUTBREAK OR EXPOSURE.— 
20
Each detention facility shall create, share, and enforce a 
21
process for notifying anyone who has recently entered or 
22
visited such facility of any COVID–19 outbreak or expo-
23
sure at such facility. 
24
23:15 Dec 21, 2020
H8913
22 
•HR 8913 IH
SEC. 8. ACCESS TO LEGAL COUNSEL. 
1
Not later than 30 days after the date of the enact-
2
ment of this Act, and monthly thereafter, the Director of 
3
U.S. Immigration and Customs Enforcement, the Com-
4
missioner of U.S. Customs and Border Protection, the Di-
5
rector of the Office of Refugee Resettlement, the head of 
6
each contract detention facility, and any senior official act-
7
ing in, or performing the duties of, any such position shall 
8
submit a report to the congressional committees referred 
9
to in section 4(c) that identifies, for each detention facility 
10
for which he or she is responsible— 
11
(1) the efforts made to ensure that each noncit-
12
izen detained in such facility has access to legal 
13
counsel; 
14
(2) if any detained noncitizen does not have ac-
15
cess to legal counsel, the changes being made to en-
16
sure universal access to legal counsel; 
17
(3) the number of telephones are available to 
18
detainees; 
19
(4) the number of detainees who have used the 
20
free telephone call minutes available to them; 
21
(5) the number of detainees who have access to 
22
video conference technology with their lawyers and 
23
the number of detainees have used video conference 
24
technology to communicate with their lawyers; 
25
23:15 Dec 21, 2020
H8913
23 
•HR 8913 IH
(6) the number of computers or internet-en-
1
abled portable electronic devices available to detain-
2
ees; and 
3
(7) the process for notifying the public when 
4
the facility is locked down because of an outbreak, 
5
including the accommodations made during such 
6
lockdowns to provide detainees with increased access 
7
to telephones or videoconferencing. 
8
SEC. 9. RIGHT OF DETAINED NONCITIZENS TO ACCESS 
9
TEST RESULTS. 
10
The Director of U.S. Immigration and Customs En-
11
forcement, the Commissioner of U.S. Customs and Border 
12
Protection, the Director of the Office of Refugee Resettle-
13
ment, the head of each contract detention facility, and any 
14
senior official acting in, or performing the duties of, any 
15
such position shall ensure that each detained noncitizen 
16
receives the results of, and any medical records related 
17
to, any COVID–19 diagnostic test administered to the 
18
noncitizen, in the noncitizen’s preferred language, and in 
19
a private and confidential manner, not later than 24 hours 
20
after such results become available. 
21
Æ 
23:15 Dec 21, 2020
H8913
